Online Only Articles

TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia

Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel
Pediatric Hematology and Oncology, Hannover Medical School, Hannover;Department of Pathology, Ruhr-University Bochum, Bochum, Germany
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel
Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel
Pediatric Hematology and Oncology, Hannover Medical School, Hannover
Vol. 104 No. 9 (2019): September, 2019 https://doi.org/10.3324/haematol.2018.205849